Tag: teva

October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
May 7, 2018

The Green Organic Dutchman Assembles World Class Senior Leadership Team

The Green Organic Dutchman Holdings Ltd.’s (“TGOD”) (TSX:TGOD) is pleased to announce the addition of several key executives including CFO,...
March 28, 2018

Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.

Xenon Pharmaceuticals (Nasdaq:XENE), a clinical stage biopharmaceutical company, reported the closing of the previously announced transaction with Teva Pharmaceuticals International...
March 16, 2018

Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents

Corcept Therapeutics (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and...
February 13, 2018

Cancer Therapies to Reach $26.61 billion by 2025, Report Says

A new report by Grandview Research suggests that global novel drug delivery systems (NDDS) in cancer therapies will reach $26.61...
February 8, 2018

How Are Pharma Stocks Affected by Opioid Lawsuits?

Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...
February 6, 2018

BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva

BioDelivery Sciences (NASDAQ:BDSI) announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals...